psychetastic
Greenlighter
- Joined
- Dec 26, 2024
- Messages
- 6
Hello everyone, I've noticed that very recently there has been discovered a very selective 5ht2b receptor antagonist that is VERY selective (578 times more selective for the 2B class than 2A or 2C) and also peripherally restricted, which means it doesn't cross that brain blood barrier (so doesn't act on the brain).
What does this mean? It means that the use of psychedelics or empathogens in people who are at risk of cardiovascular disease or have some heart condition now could use such substances safely. Many substances including LSD, mescaline, MDMA, (M)APB5/6, induce strain on the heart due to potent 5ht2b agonism, which on the long run if used too frequently can cause cardiovascular vulvopathy or hypertension.
A 5ht2b selective antagonism that doesn't enter the brain is ideal for this task, as prevents cardiovascular damage in the body while keeping the 5ht2b receptors on the brain intact so you can have the whole psychedelic experience.
I'll leave you the wikipedia link of the new substance here: VU0530244
What does this mean? It means that the use of psychedelics or empathogens in people who are at risk of cardiovascular disease or have some heart condition now could use such substances safely. Many substances including LSD, mescaline, MDMA, (M)APB5/6, induce strain on the heart due to potent 5ht2b agonism, which on the long run if used too frequently can cause cardiovascular vulvopathy or hypertension.
A 5ht2b selective antagonism that doesn't enter the brain is ideal for this task, as prevents cardiovascular damage in the body while keeping the 5ht2b receptors on the brain intact so you can have the whole psychedelic experience.
I'll leave you the wikipedia link of the new substance here: VU0530244
Last edited: